INS and type 1 diabetes mellitus: As noted above, Type 1 diabetes (T1D) is caused by immune-mediated destruction of insulin-secreting β cells in the pancreas, and in vivo inhibition of eIF5AHyp by GC7 treatment has been shown to delay the onset of T1D in a humanized mouse model of T1D [44].